cardiovascular diseasedisease causationpublic healthepidemiologic informationCirculation. 1996 Oct 1;94(7):1787. Comment; Letterdoi:10.1016/j.nurpra.2009.09.010Sandy WilbanksSandra WilbanksJournal for Nurse PractitionersM. Karakas and W. Koenig, "CRP in cardiovascular disease," Herz, vol. 34, no. ...
17. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103(13):1813-8. 18. Zebrack JS, Muhlestein JB, Horne BD, Anderson...
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 2004;110:e545-9. Smith SC Jr, Anderson JL, Cannon RO 3rd, et al. CDC/AHA Workshop on Markers of ...
三种生物标志物组合时,当它们都升高时,中风风险增加近2倍;当hs-CRP和同型半胱氨酸都升高时,中风风险增加79%。 来源:Lipoprotein(a), high-sensitivity c-reactive protein, homocysteine and cardiovascular disease in the Multi-Ethni...
当然，我们不能仅仅依赖CRP的检测结果来判断疾病，医生还需结合患者的临床表现、病史以及其他检查结果进行综合评估。只有这样，才能做出准确的诊断和制定合理的治疗方案。#健康# 参考文献：1. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in ...
There is persuasive evidence that C-reactive protein (CRP), a marker of inflammation, is associated with cardiovascular disease. In this study, researchers compared the value of CRP levels and LDL-cholesterol levels for predicting cardiovascular risk. ...
来源:Lipoprotein(a), high-sensitivity c-reactive protein, homocysteine and cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Am J Prev Cardiol, 11 December 2024 转载:请标明“中国循环杂志”
[2] Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men." N Engl J Med. 1997;336(14):973 - 979.[3] Pai JK, Pischon T, Ma J, et al. "Inflammatory markers and the risk of coronary...
Blood measurements of hs-CRP are often performed to assess the risk of future heart disease. It has also been suggested that hs-CRP can be used to target therapy and tailor risk modification to prevent cardiovascular disease (CVD). Therefore it is important to understand when and why these me...
[2] Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men." N Engl J Med. 1997;336(14):973 - 979. [3] Pai JK, Pischon T, Ma J, et al. "Inflammatory markers and the risk of coronar...